Synchrony 2019 Presentations

The microbiome and autism – basic research to clinical trials

Sarkis Mazmanian, PhD
Luis and Nelly Soux Professor of Microbiology, Caltech

Antipurinergic therapy to address core disabilities of ASD 

Robert Naviaux, MD, PhD

UCSD

Microbiota Transfer Therapy for Children with ASD and GI disorders: Summary of Phase 1 and Follow-Up

James Adams, PhD

Rosa Krajmalnik Brown, PhD

ASU

Brain Plasticity in ASD

Michael Merzenich, PhD

Professor (Emeritus), UCSF

CSO, Posit Science Corporation

CSO, Stronger Brains

Genomic Testing in Autism Spectrum Disorder

David Bick, MD

Chief Medical Officer & Faculty Investigator,

Hudson Alpha Institute for Biotechnology

A new evidence-based method for choosing the most effective treatments for autism

Daniel Rossignol, MD, FAAFP

Rossignol Medical Center

The End ME/CFS Project

Ronald W. Davis, PhD

Professor of Biochemistry and Genetics,

Director of the Stanford Genome Technology Center

Stanford University School of Medicine

Collaborative Care in ABA Treatment for Autism 

Dennis Dixon, PhD

Chief Clinical Officer at the Center for Autism and Related Disorders (CARD)

Disruption of Brain development and function by Folate Receptor Antibodies: Treatment of Autism Spectrum Disorders

Edward Quadros, PhD

Research Professor at SUNY

Mitochondrial Medicine and Autism

Richard Boles, MD

Mitochondrial and Molecular Medicine

Seizures and Epilepsy in Autism Spectrum Disorder

Richard Frye, MD, PhD

Chief of the Division of Neurodevelopment Disorders and Director of the Autism Program at Phoenix Children’s Hospital

Autism-Associated Enterocolitis Treatment Study

Arthur Krigsman, MD

Pediatric Gastroenterologist